Walleye Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Walleye Capital's LLY Position: Q1 2026 in Review
Walleye Capital reduced its Eli Lilly (LLY) stake by 43% in Q1 2026, selling an estimated $15.7M and leaving 20,644 shares worth $19M. The position accounts for 0.08% of the portfolio, ranked #210.
Walleye Capital first reported a position in LLY in Q1 2019 and has held it in 22 quarters since. The position peaked at $47M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Walleye Capital held 20,644 shares of Eli Lilly worth $19M as of Q1 2026.
- Walleye Capital sold 15,497 Eli Lilly shares in Q1 2026, an estimated $15.7M.
- Eli Lilly made up 0.08% of Walleye Capital's portfolio in Q1 2026, its #210 holding.
- Walleye Capital first reported a position in Eli Lilly in Q1 2019 and has held it in 22 quarters since.
- Walleye Capital's Eli Lilly position peaked at $47M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.